These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


233 related items for PubMed ID: 1949240

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Severe hyperlipidemia due to multiple factors in a child with nephrotic syndrome.
    Ongkingco JR, Mann WA, Ruley EJ, Gregg RE.
    Child Nephrol Urol; 1991; 11(2):107-10. PubMed ID: 1756519
    [Abstract] [Full Text] [Related]

  • 4. Rationale and management of hyperlipidemia of the nephrotic syndrome.
    Grundy SM, Vega GL.
    Am J Med; 1989 Nov; 87(5N):3N-11N. PubMed ID: 2486542
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Hepatic tissue sterol regulatory element binding protein 2 and low-density lipoprotein receptor in nephrotic syndrome.
    Kim CH, Kim HJ, Mitsuhashi M, Vaziri ND.
    Metabolism; 2007 Oct; 56(10):1377-82. PubMed ID: 17884448
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Mutual relation between hyperlipidemia and nephrotic syndrome].
    Kraise Y, Averbuch M, Schwartz D, Kornovsky R, Levo Y.
    Harefuah; 1991 Dec 15; 121(12):521-4. PubMed ID: 1794760
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Lipid abnormalities in chronic renal failure, nephrotic syndrome and dialysis.
    Kes P.
    Acta Med Croatica; 2001 Dec 15; 55(4-5):177-86. PubMed ID: 12398021
    [Abstract] [Full Text] [Related]

  • 12. Proteinuria, hyperlipidemia, and the kidney.
    Hutchison FN.
    Miner Electrolyte Metab; 1993 Dec 15; 19(3):127-36. PubMed ID: 8232099
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Blood lipid disorders in the nephrotic syndrome. Physiopathological aspects and therapeutic prospects].
    Campanacci L.
    Minerva Med; 1976 Sep 30; 67(46):2951-60. PubMed ID: 787832
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Dyslipidemias in renal diseases: pathogenesis and treatment].
    Cuevas A, Maíz A, Arteaga A.
    Rev Med Chil; 1998 Mar 30; 126(3):315-21. PubMed ID: 9674303
    [Abstract] [Full Text] [Related]

  • 17. Nephrotic syndrome in adults: diagnosis and management.
    Kodner C.
    Am Fam Physician; 2009 Nov 15; 80(10):1129-34. PubMed ID: 19904897
    [Abstract] [Full Text] [Related]

  • 18. The potential role of HMG-CoA reductase inhibitors in pediatric nephrotic syndrome.
    Prescott WA, Streetman DA, Streetman DS.
    Ann Pharmacother; 2004 Dec 15; 38(12):2105-14. PubMed ID: 15507504
    [Abstract] [Full Text] [Related]

  • 19. [Lipoprotein disorders in chronic kidney failure, nephrotic syndrome and dialysis].
    Kes P, Reiner Z, Brunetta B.
    Lijec Vjesn; 2002 Dec 15; 124(11-12):372-7. PubMed ID: 12679979
    [Abstract] [Full Text] [Related]

  • 20. Premature acute myocardial infarction in a child with nephrotic syndrome.
    Silva JM, Oliveira EA, Marino VS, Oliveira JS, Torres RM, Ribeiro AL, Simal CJ, Ribeiro MC.
    Pediatr Nephrol; 2002 Mar 15; 17(3):169-72. PubMed ID: 11956853
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.